Sugar-sweetened beverage consumption from 1998-2017: Findings from the health behaviour in school-aged children/school health research network in Wales.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 10 07 2020
accepted: 06 03 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 16 9 2021
Statut: epublish

Résumé

To date no study has examined time trends in adolescent consumption of sugar-sweetened beverages and energy drinks, or modelled change in inequalities over time. The present study aimed to fill this gap by identifying historical trends among secondary school students in Wales, United Kingdom. The present study includes 11-16 year olds who completed the Health Behaviour in School-aged Children (HBSC) survey and the Welsh School Health Research Network (SHRN) survey between 1998 to 2017. Multinomial regression models were employed alongside tests for interaction effects. A total of 176,094 student responses were assessed. From 1998 to 2017, the prevalence of daily sugar-sweetened beverage consumption decreased (57% to 18%) while weekly consumption has remained constant since 2006 (49% to 52%). From 2013 to 2017, daily consumption of energy drinks remained stable (6%) while weekly consumption reports steadily decreased (23% to 15%). Boys, older children and those from a low socioeconomic group reported higher consumption rates of sugar-sweetened beverages and energy drinks. Consumption according to socioeconomic group was the only characteristic to show a statistically significant change over time, revealing a widening disparity between sugar-sweetened beverage consumption rates of those from low and high socioeconomic groups. Findings indicate a positive shift in overall consumption rates of both sugar-sweetened beverages and energy drinks. Adolescents from a low socioeconomic group however were consistently shown to report unfavourable sugar-sweetened beverages consumption when compared to peers from high socioeconomic group. Given the established longer term impacts of sugar-sweetened beverage and energy drink consumption on adolescent health outcomes, urgent policy action is required to reduce overall consumption rates, with close attention to equity of impact throughout policy design and evaluation plans.

Identifiants

pubmed: 33852585
doi: 10.1371/journal.pone.0248847
pii: PONE-D-20-21401
pmc: PMC8046241
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0248847

Subventions

Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L002787/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701875
Pays : United Kingdom
Organisme : HCRW_
ID : HCRW_HF-16-1164
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Med. 2020 Feb 11;17(2):e1003025
pubmed: 32045418
J Paediatr Child Health. 2018 Mar;54(3):279-283
pubmed: 28905482
Int J Public Health. 2009 Sep;54 Suppl 2:131-9
pubmed: 19639260
BMJ Open. 2017 Dec 14;7(12):e018136
pubmed: 29242395
Nutr Health. 2020 Mar;26(1):3-8
pubmed: 31965902
JAMA. 2004 Aug 25;292(8):927-34
pubmed: 15328324
Front Public Health. 2014 Oct 14;2:134
pubmed: 25360435
BMJ. 2013 Oct 31;347:f6189
pubmed: 24179043
Tob Control. 2020 Mar;29(2):207-216
pubmed: 30936390
Health Place. 2016 May;39:43-50
pubmed: 26945871
Child Indic Res. 2016;9:233-245
pubmed: 26925177
BMC Obes. 2019 Jan 3;6:1
pubmed: 30619612
Can J Public Health. 2015 Mar 12;106(3):e101-8
pubmed: 26125234
Am J Clin Nutr. 1994 May;59(5):955-9
pubmed: 8172099
Int J Public Health. 2009 Sep;54 Suppl 2:140-50
pubmed: 19639259
J Zhejiang Univ Sci B. 2009 May;10(5):395-9
pubmed: 19434767
Br J Nutr. 2005 Jun;93(6):923-31
pubmed: 16022763
BMJ Open. 2016 Oct 8;6(10):e010380
pubmed: 27855083
Soc Sci Med. 2008 Mar;66(6):1429-36
pubmed: 18179852
J Addict Med. 2014 Jan-Feb;8(1):6-13
pubmed: 24481080
J Acad Nutr Diet. 2016 Feb;116(2):240-50.e2
pubmed: 26482095
Child Indic Res. 2016;9:771-784
pubmed: 27489572
Eur Arch Paediatr Dent. 2020 Feb;21(1):109-117
pubmed: 31177478
Crit Rev Food Sci Nutr. 2015;55(7):988-1004
pubmed: 24915353
Am J Prev Med. 2013 Jun;44(6):573-82
pubmed: 23683974
Am J Prev Med. 2019 Jun;56(6):827-833
pubmed: 31005465

Auteurs

Kelly Morgan (K)

Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, United Kingdom.

Emily Lowthian (E)

Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, United Kingdom.

Jemma Hawkins (J)

Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, United Kingdom.

Britt Hallingberg (B)

Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom.

Manal Alhumud (M)

Applied Medical Sciences, Community Health Sciences, King Saudi University, Riyadh, Saudi Arabia.

Chris Roberts (C)

Knowledge and Analytical Services, Welsh Government, Cardiff, United Kingdom.

Simon Murphy (S)

Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, United Kingdom.

Graham Moore (G)

Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH